Soleno Therapeutics, Inc. (SLNO): Price and Financial Metrics
GET POWR RATINGS... FREE!
SLNO Stock Price Chart Interactive Chart >
SLNO Price/Volume Stats
| Current price | $2.81 | 52-week high | $6.30 |
| Prev. close | $2.59 | 52-week low | $0.85 |
| Day low | $2.57 | Volume | 110,053 |
| Day high | $2.84 | Avg. volume | 275,911 |
| 50-day MA | $1.63 | Dividend yield | N/A |
| 200-day MA | $2.13 | Market Cap | 22.93M |
Soleno Therapeutics, Inc. (SLNO) Company Bio
Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The companys lead candidate, diazoxide choline controlled-release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. May 2017. Soleno Therapeutics, Inc. was founded in 1999 and is based in Redwood City, California.
Latest SLNO News From Around the Web
Below are the latest news stories about SOLENO THERAPEUTICS INC that investors may wish to consider to help them evaluate SLNO as an investment opportunity.
Soleno Therapeutics, Inc. (SLNO) Upgraded to Strong Buy: What Does It Mean for the Stock?Soleno Therapeutics, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayThe final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday! |
Soleno Therapeutics Inc. (NASDAQ: SLNO) Recovered 42.18% From The 52-Week Low, And Now It’s -76.10% YTD – This Is What You Do NowSoleno Therapeutics Inc. (NASDAQ:SLNO)’s traded shares stood at 2.29 million during the last session, with the company’s beta value hitting 0.35. At the close of trading, the stock’s price was $1.47. The SLNO share’s 52-week high remains $8.13, putting it -453.06% down since that peak but still an impressive 42.18% since price per share fell … Soleno Therapeutics Inc. (NASDAQ: SLNO) Recovered 42.18% From The 52-Week Low, And Now It’s -76.10% YTD – This Is What You Do Now Read More » |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuedayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning! |
Why Is Soleno Therapeutics (SLNO) Stock Up 130% Today?With Soleno Therapeutics receiving a financial commitment, SLNO stock skyrocketed. |
SLNO Price Returns
| 1-mo | 43.37% |
| 3-mo | 167.62% |
| 6-mo | 9.55% |
| 1-year | -41.62% |
| 3-year | -94.41% |
| 5-year | -89.90% |
| YTD | 41.92% |
| 2022 | -67.80% |
| 2021 | -78.76% |
| 2020 | -34.35% |
| 2019 | 71.93% |
| 2018 | -5.00% |
Loading social stream, please wait...